In reply [4]

Archives of Internal Medicine

Volumn 166, Issue 3, 2006, Pages 368-369

  Rahman, Mahboob ^a   Pressel, Sara L ^b   Davis, Barry R ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CHLORTALIDONE; LISINOPRIL;

BLOOD PRESSURE REGULATION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 32644443236     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.166.3.368-c     Document Type: Letter

References (1)

1. Rahman M, Pressel S, Davis BR, et al; ALLHAT Collaborative Research Group. Renal outcomes in high-risk hypertensive patients treated with an angiotensinconverting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2005;165:936-946.